Both in Pharmaceuticals
Generate Biomedicines vs Braveheart Bio
Over the past year GENB returned −11.7% and BRVE returned −20.3%; their daily moves had a correlation of 0.21.
GENB −11.7% BRVE −20.3%Growth of $1, one year, split-adjusted
| Metric | GENB | BRVE |
|---|---|---|
| Price | $13.88 | $21.24 |
| Market cap | $1.78B | $1.91B |
| Today | +5.03% | +0.95% |
| 1 month | −0.3% | −0.5% |
| 6 months | — | — |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −1065.2% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $452.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | — | — |
| Short % of float | 15.4% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).